January 18, 2019
Prof. Kohei Kaku, Kawasaki Medical School It is important to always use insulin when Astellas Pharma’s SGLT2 inhibitor Suglat (ipragliflozin), which was approved for an additional indication of type 1 diabetes late last month, is given to type 1 diabetes...read more